Pliant Therapeutics (PLRX) Retained Earnings (2019 - 2026)
Pliant Therapeutics (PLRX) reported Retained Earnings of -$341000.0 for Q1 2026, up 99.96% year-over-year from -$170537.9 in Q1 2025, and up 99.96% quarter-over-quarter from -$859.4 million in Q4 2025.
Pliant Therapeutics (PLRX) Retained Earnings (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has 8 years of Retained Earnings data on file, last reported at -$341000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$341000.0, up 99.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$341000.0 (up 99.96% YoY), and the FY2025 annual result was -$859.4 million, down 21.03% from the prior year.
- Retained Earnings rose to -$341000.0 in Q1 2026 per PLRX's latest filing, from -$859.4 million in the prior quarter.
- Over five years, Retained Earnings peaked at $848000.0 in Q3 2024 and troughed at -$859.4 million in Q4 2025.
- A 5-year average of -$249.4 million and a median of -$2.0 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 144.47% in 2024, then slumped 156590.8% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$2.0 million in 2022, then sank by 25423.39% to -$499.7 million in 2023, then plunged by 42.08% to -$710.1 million in 2024, then fell by 21.03% to -$859.4 million in 2025, then surged by 99.96% to -$341000.0 in 2026.
- Business Quant data shows PLRX's Retained Earnings at -$341000.0 in Q1 2026, -$859.4 million in Q4 2025, and $34000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | -341,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -341,000.00 |
| Dec 31, 2025 | -859.40 Mn |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -766.22 Mn |
| Dec 31, 2024 | -710.05 Mn |
| Sep 30, 2024 | 848,000.00 |
| Jun 30, 2024 | -602.56 Mn |
| Mar 31, 2024 | -489,000.00 |
| Dec 31, 2023 | -499.75 Mn |
| Sep 30, 2023 | -1.91 Mn |
| Jun 30, 2023 | -417.15 Mn |
| Mar 31, 2023 | -375.96 Mn |
| Dec 31, 2022 | -1.96 Mn |
| Sep 30, 2022 | -2.45 Mn |
| Jun 30, 2022 | -1.26 Mn |
| Mar 31, 2022 | -950,000.00 |
| Dec 31, 2021 | -201,000.00 |
| Sep 30, 2021 | -190.56 Mn |
| Jun 30, 2021 | -30,000.00 |